Top

Published in:

01-03-2008 | Short Report

An estimation of indirect costs caused by acute rotavirus gastroenteritis in a Galician area, Spain

Authors: Federico Martinón-Torres, Marta Bouzón-Alejandro, Maria López-Sousa, Lorenzo Redondo-Collazo, Santiago Almeida-Agudín, Consuelo Astorgano-Fernández, José María Martinón-Sánchez

Published in: European Journal of Pediatrics | Issue 3/2008

Excerpt

Despite the fact that rotavirus gastroenteritis is currently considered to be the most common pediatric disease in the European Community, preventable by vaccination, specific data about the indirect economic burden generated by rotavirus in Europe are limited [9]. In Spain, economic data on rotavirus are even more limited, and its impact in terms of indirect costs is unknown [2‐4]. …

Diez-Domingo J, Martin IO, Sanz AB, Lopez AG, Martinez CC, Boronat CP (2006) Rotavirus gastroenteritis among children under five years of age in Valencia, Spain. Pediatr Infect Dis J 25:455–457PubMedCrossRef

Gil A, Carrasco P, Jimenez R, San-Martin M, Oyaguez I, Gonzalez A (2004) Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000. Vaccine 22:2221–2225PubMedCrossRef

Gil de Miguel A, Carrasco Garrido P, Esteban Hernandez J, San-Martin Rodriguez M, Gonzalez Lopez A (2006) Burden of hospitalizations attributable to rotavirus infection in children in the Autonomous Region of Madrid, Spain, period 1999–2000. An Pediatr (Barc) 64:530–535CrossRef

Gimenez Sanchez F, Martinon Torres F, Bernaola Iturbe E, Baca Cots M, De Juan Martin F, Diez Delgado J (2006) The role of the rotavirus vaccine in childhood vaccination schedules. An Pediatr (Barc) 64:573–577CrossRef

Griffiths RI, Anderson GF, Powe NR, Oliveras E, Herbert RJ, Grant CC, Davidson BL (1995) Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial. Arch Pediatr Adolesc Med 149:407–414PubMed

Lee BP, Azimi PH, Staat MA, Louie L, Parada E, Berke T, Ward RL, Bernstein DI, Matson DO (2005) Nonmedical costs associated with rotavirus disease requiring hospitalization. Pediatr Infect Dis J 24:984–988PubMedCrossRef

Liddle JL, Burgess MA, Gilbert GL, Hanson RM, McIntyre PB, Bishop RF, Ferson MJ (1997) Rotavirus gastroenteritis: impact on young children, their families and the health care system. Med J Aus 167:304–307

Roberts JA, Cumberland P, Sockett PN, Wheeler J, Rodrigues LC, Sethi D, Roderick PJ; Infectious Intestinal Disease Study Executive (2003) The study of infectious intestinal disease in England: socio-economic impact. Epidemiol Infect 55:190–195

Soriano-Gabarro M, Mrukowicz J, Vesikari T, Verstraeten T (2006) Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 25:S7–S11PubMedCrossRef

10.

Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI (1998) Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 279:1371–1376PubMedCrossRef

Title: An estimation of indirect costs caused by acute rotavirus gastroenteritis in a Galician area, Spain
Authors: Federico Martinón-Torres
Marta Bouzón-Alejandro
Maria López-Sousa
Lorenzo Redondo-Collazo
Santiago Almeida-Agudín
Consuelo Astorgano-Fernández
José María Martinón-Sánchez
Publication date: 01-03-2008
Publisher: Springer-Verlag
Published in: European Journal of Pediatrics / Issue 3/2008
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-007-0466-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

An estimation of indirect costs caused by acute rotavirus gastroenteritis in a Galician area, Spain

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2008

Steep increase of incidence of childhood diabetes since 1999 in Austria. Time trend analysis 1979–2005. A nationwide study

Nanoduct® sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis

Abstracts

Author’s reply to the correspondence letter from Dr. S. Meyer et al. entitled arginine-vasopressin as a rescue therapy in children and neonates for catecholamine-resistant shock

Arginine-vasopressin as a rescue therapy in children and neonates for catecholamine-resistant shock

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy